![Peter M. Strumph](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter M. Strumph
Directeur/Membre du Conseil chez Amygdala Neurosciences, Inc.
Provenance du réseau au premier degré de Peter M. Strumph
Entité | Type d'entité | Industrie | |
---|---|---|---|
CV Therapeutics, Inc.
![]() CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases
39
| Extinct | Biotechnology | 39 |
Public Company | Chemicals: Specialty | 10 | |
Nile Therapeutics, Inc. /Old/
8
| Extinct | Pharmaceuticals: Major | 8 |
Amygdala Neurosciences, Inc.
![]() Amygdala Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Amygdala Neurosciences, Inc. is a biopharmaceutical company. The firm focuses on improving public health by developing and commercializing therapy to treat substance use disorders. Its development programs include treatment and prevention of opioid, nicotine, alcohol and cocaine use disorders. The company was founded by Lou Lange, Ivan Diamond, Peter Strumph, Brent Blackburn, and Adrienne MacMillan in 2015 and is headquartered in San Francisco, CA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Public Company | Pharmaceuticals: Major | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Peter M. Strumph via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Treasurer Corporate Officer/Principal Founder General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Human Resources Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal | |
Scios, Inc.
![]() Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Maxygen, Inc.
![]() Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
RESVERLOGIX CORP. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
CYMABAY THERAPEUTICS, INC. | Biotechnology | Human Resources Officer Chairman Corporate Officer/Principal | |
NEPHROS, INC. | Medical Specialties | Chief Executive Officer Chief Executive Officer | |
CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Paramount BioCapital, Inc.
![]() Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States. | Investment Managers | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Two River Group Holdings LLC
![]() Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Investment Managers | Founder Founder Private Equity Investor | |
Kirax Corp.
![]() Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Riverbank Capital Securities, Inc.
![]() Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Part of Two River Group Holdings LLC, Riverbank Capital Securities, Inc. deals securities. The company is based in New York, NY. | Investment Banks/Brokers | Director/Board Member Director/Board Member Chairman Corporate Officer/Principal | |
Danube Pharmaceuticals, Inc.
![]() Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree | |
Stanford University | College/University | Undergraduate Degree Masters Business Admin Graduate Degree | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Doctorate Degree | |
AFFYMAX, INC. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal Comptroller/Controller/Auditor | |
Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree | |
Orion Biomedical Fund LP | Corporate Officer/Principal Chief Investment Officer Corporate Officer/Principal | ||
Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree Graduate Degree | |
Rutgers State University of New Jersey | College/University | Doctorate Degree Doctorate Degree | |
University of London | College/University | Graduate Degree Doctorate Degree | |
Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
The Ohio University
![]() The Ohio University Other Consumer ServicesConsumer Services Central Hockey League operates a professional minor league hockey teams playing in small to medium-sized markets primarily in central and southwestern US states. The league, which was started in 1992, is managed and operated by WPHL, a subsidiary of Global Entertainment Corporation. | College/University | Undergraduate Degree Graduate Degree | |
The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
The North Carolina Biotechnology Center
![]() The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Internet Software/Services | Chairman Director/Board Member | |
CYCLACEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
RELYPSA INC | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder Founder Treasurer | |
Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
KITE PHARMA INC | Biotechnology | Founder Founder Comptroller/Controller/Auditor | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Harvard Law School | College/University | Graduate Degree Graduate Degree | |
AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Human Resources Officer General Counsel | |
Calysta, Inc.
![]() Calysta, Inc. Agricultural Commodities/MillingProcess Industries Calysta, Inc. provides sustainable industrial products for food and energy security. The firm develops new Biological Gas-to-Liquids and Biological Gas-to-Chemicals technologies using methane, the primary component of natural gas. It’s technology allows conversion of a plentiful energy resource into high value chemicals and transportation fuels. The company was founded in 2012 by Joshua Silverman and Alan Shaw and is headquartered in Menlo Park, CA. | Agricultural Commodities/Milling | Founder Corporate Officer/Principal | |
California Life Sciences Association
![]() California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Specialty Renal Products, Inc.
![]() Specialty Renal Products, Inc. Medical SpecialtiesHealth Technology Specialty Renal Products, Inc. develops medical devices for patients with renal diseases. The firm focuses on the development of products for patients with renal disease, including a hemodiafiltration (HDF) system for the treatment of patients with End Stage Renal Disease (ESRD). The company was founded in 2018 and is headquartered in Nashville, TN. | Medical Specialties | Chief Executive Officer Director/Board Member | |
Recardia Therapeutics, Inc. | Director/Board Member President |
Statistiques
Internationale
Etats-Unis | 47 |
Royaume-Uni | 3 |
Canada | 2 |
Suède | 2 |
Sectorielle
Health Technology | 27 |
Consumer Services | 13 |
Finance | 5 |
Commercial Services | 4 |
Technology Services | 2 |
Opérationnelle
Director/Board Member | 358 |
Corporate Officer/Principal | 171 |
Independent Dir/Board Member | 77 |
Undergraduate Degree | 49 |
Founder | 47 |
Relations les plus connectées
Insiders | |
---|---|
Peter Hutt | 69 |
Joshua Kazam | 43 |
Kenneth Lee | 40 |
Louis Lange | 35 |
Peter Morgan Kash | 32 |
Santo Costa | 28 |
David Tanen | 25 |
Cam Gallagher | 24 |
Dan Spiegelman | 24 |
R. Greer | 23 |
Thomas Shenk | 21 |
Anders Waas | 21 |
Pedro Isamu Mizutani | 21 |
Paul Anthony Mieyal | 18 |
Alan R. Shaw | 17 |
- Bourse
- Insiders
- Peter M. Strumph
- Connexions Sociétés